Plant ID: NPO26639
Plant Latin Name: Ardisia crenata
Taxonomy Genus: Ardisia
Taxonomy Family: Primulaceae
NCBI TaxonomyDB:
13345
Plant-of-the-World-Online:
586890-1
Anodyne; Depurative; Febrifuge
United States; Australia; Myanmar; South Africa; Philippines; India; Cambodia; Mauritius; Seychelles; China; Vietnam; Laos; Japan; Taiwan; Thailand
TDP1; ALOX12; ALOX15; USP2; | |
MAPK1; | |
CA2; CA7; CA6; CA12; CA14; CA9; CA3; CA5A; CA1; | |
ALOX5; | |
KAT2B; | |
XIAP; | |
MPEG1; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Bromodomain | KAT2B | Histone acetyltransferase PCAF | Q92831 | CHEMBL5500 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transferase | XIAP | Inhibitor of apoptosis protein 3 | P98170 | CHEMBL4198 |
Unclassified | MPEG1 | Macrophage-expressed gene 1 protein | Q2M385 | CHEMBL3414409 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 2.860E-07 | 4.791E-04 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0019372; lipoxygenase pathway | 3.776E-07 | 5.873E-04 | ALOX12, ALOX15, ALOX5 |
BP | GO:0008152; metabolic process | GO:2001303; lipoxin A4 biosynthetic process | 8.202E-07 | 8.504E-04 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 8.202E-07 | 8.504E-04 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.357E-25 | 5.133E-21 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 2.459E-06 | 2.060E-03 | CA2, CA7 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 2.459E-06 | 2.060E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0051120; hepoxilin A3 synthase activity | 2.459E-06 | 2.060E-03 | ALOX12, ALOX15 |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 3.005E-06 | 2.423E-03 | ALOX12, ALOX15, ALOX5 |
BP | GO:0008152; metabolic process | GO:0051122; hepoxilin biosynthetic process | 8.188E-06 | 5.752E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.228E-05 | 8.100E-03 | CA1, CA2 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 3.299E-20 | 3.592E-16 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.724E-18 | 1.483E-14 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 8.365E-25 | 8.532E-23 | CA12, CA1, CA3, CA2, CA5A, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 2.684E-06 | 1.369E-04 | ALOX5, ALOX15, MAPK1, ALOX12 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.239E-05 | 7.614E-04 | ALOX5, ALOX15, ALOX12 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 1.531E-04 | 3.905E-03 | ALOX5, XIAP, MAPK1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 4.965E-03 | 1.013E-01 | KAT2B, MAPK1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 6.916E-03 | 1.176E-01 | XIAP, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 7.717E-02 | 1.385E-01 | MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05222 | Small cell lung cancer | 7.467E-02 | 1.385E-01 | XIAP |
09160 Human Diseases | 09167 Infectious diseases | hsa05142 | Chagas disease (American trypanosomiasis) | 8.961E-02 | 1.385E-01 | MAPK1 |
09150 Organismal Systems | 09151 Immune system | hsa04660 | T cell receptor signaling pathway | 8.961E-02 | 1.385E-01 | MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | ALOX5; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ALOX5; |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | ALOX5; |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatitis | L20-L30 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | ALOX5; |
J00-J99: Diseases of the respiratory system | Respiratory disease | J00-J99 | ALOX5; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | ALOX5; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Pruritus | L29 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | ALOX5; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Allergy | T78.4 | ALOX5; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
I00-I99: Diseases of the circulatory system | Thrombosis | I80-I82 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | ALOX5; |
J00-J99: Diseases of the respiratory system | Rhinitis | J00, J30, J31.0 | ALOX5; |